I-Tirzepatide CAS:2023788-19-2 Isithombe Esifakiwe Somhlinzeki Womkhiqizi

Tirzepatide CAS:2023788-19-2 Umkhiqizi Supplier

I-Tirzepatide yathuthukiswa njenge-agonist embaxambili kukho kokubili i-GLP-1 kanye ne-gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018).Ngokufana ne-GLP-1, i-GIP iyi-hormone ye-incretin esebenza ukunxenxa ukukhiqizwa kwe-insulini.I-Tirzepatide isesigabeni sesi-3 sokuthuthukiswa kwabantu abadala abakhuluphele noma abakhuluphele ngokweqile abane-comorbidity ehlobene nesisindo futhi njengamanje ingaphansi kokubuyekezwa okusemthethweni njengokwelashwa kwabantu abadala abanesifo sikashukela sohlobo 2. .Iphinde icutshungulwe njengokwelashwa okungaba khona kwe-steatohepatitis (NASH) engeyona utshwala kanye nokuhluleka kwenhliziyo ngengxenye egcinwe ejection (HFpEF).

Oda noma Cela I-Quote

Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Isicelo kanye Nomphumela

I-Tirzepatide isetshenziswa ngokudla okufanele kanye nohlelo lokuzivocavoca ukulawula ushukela wegazi ophakeme kubantu abanesifo sikashukela sohlobo lwe-2.Ukulawula ushukela ophezulu wegazi kusiza ukuvimbela ukulimala kwezinso, ubumpumputhe, izinkinga zezinzwa, ukulahlekelwa izitho nezinkinga zokusebenza kocansi.I-Tirzepatide inobudlelwane obukhulu nama-GIP receptors kunama-GLP-1 receptors, futhi lokhu kuziphatha kwe-agonist okukabili kuye kwaboniswa ukukhiqiza ukuncipha okukhulu. I-hyperglycemia uma iqhathaniswa ne-GLP-1 receptor agonist ekhethiwe.Ucwaningo lwamasignali lubonise ukuthi lokhu kungenxa ye-tirzepatide elingisa izenzo ze-GIP yemvelo kumamukeli we-GIP.

Isampula Lomkhiqizo

Ukupakishwa komkhiqizo:

Ulwazi Olwengeziwe:

Ukwakheka	Na
Isivivinyo	99%
Ukubukeka	Impushana emhlophe
Inombolo ye-CAS.	2023788-19-2
Ukupakisha	25KG
I-Shelf Life	iminyaka engu-2
Isitoreji	Gcina endaweni epholile neyomile
Isitifiketi	ISO.